我要投票 哈药牌在补铁锌硒行业中的票数:351
· 外 推 电 报 ·
2025-04-26 13:46:31 星期六

【哈药牌是哪个国家的品牌?】

哈药牌是什么牌子?「哈药牌」是 哈药集团有限公司 旗下著名品牌。该品牌发源于黑龙江,由创始人张利君在1989期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力哈药牌品牌出海!通过在本页面挂载哈药牌品牌的产品链接和联系方式,可以提高哈药牌产品曝光!跨境电商爆单神器,目前只要100元/年哦~

哈药集团制药总厂始建于1958年,经过半个世纪的艰苦创业,不懈追求,已经由名不见经传的简陋小厂发展成为国内拥有先进理念、科学管理、核心竞争力的大型综合性制药企业,位列全国医药“百强”企业之首。年销售收入近50亿元,出口创汇1亿多美元。

公司主要生产青霉素类、头孢菌素类、大环内酯类抗生素以及心脑血管用药等30种原料药、原料中间体和100多种制剂品种。青霉素工业盐和7ACA两大母核的技术质量指标始终处于国内领先、国际一流水平。

企业拥有技术装备先进、管理体系完善的科研开发中心、质量检验中心、计控中心及生产、销售、服务等系统和职能部门,拥有精干、专业、严谨、高效的管理团队和敬业、忠诚、团结、向上的员工队伍。

企业先后自行研制开发了三类新药凯兰欣、铃兰欣、头孢吡肟、头孢替唑等,四类新药头孢唑肟钠、盐酸头孢替安、、盐酸头孢他美酯等几十种新产品。头孢替安无菌原料药是国内独家品种,获得了省科技进步奖、国家重点新稆证书;头孢美唑工艺技术的攻关成果获得国家重点新产品证书和医药行业科技进步一等奖。

企业的主导产品青霉素、头孢菌素类原粉和制剂均通过国家药品监督管理局GMP认证;青霉素工业钾盐通过了美国FDA认证;部分原料药和制剂通过南非卫生部的GMP认证;头孢唑林钠、头孢曲松钠原料药通过欧洲EDMF认证。

哈药集团制药总厂是中国重点抗生素生产和出口基地。营销系统下设九个销售公司,在全国29个省分布有62个办事处、600余名销售业务员,拥有5600多个经销商,产品覆盖除港澳台以外的所有区县。国际贸易营销网络覆盖中东、东南亚、南美、印度、俄罗斯以及原独联体其它国家、非洲、欧盟等市场,产品远销40多个国家和地区。

“哈药”品牌在2010年中国最有价值的品牌评价中,价值已达到160.62亿元,成为中国医药行业之冠和黑龙江省第一品牌。哈药集团制药总厂是国家级重合同守信用单位,哈药产品以优质、高效、安全在广大客户和消费者心目中享有盛誉。

哈药集团制药总厂秉承“厚德载物、兢兢以强”的企业精神,始终以发展和壮大祖国医药事业、造福人类健康为已任,孜孜以求,矢志超越,全力打造中国最具科技实力、经营潜力、发展张力、文化魅力的规范化、现代化、国际化的医药界强企,努力为社会、为人类创造更大的价值。

英文翻译:Harbin Pharmaceutical Group Pharmaceutical General Factory was founded in 1958. After half a century of hard work and unremitting pursuit, it has developed from a humble small factory to a large comprehensive pharmaceutical enterprise with advanced concept, scientific management and core competitiveness, ranking first among the "top 100" pharmaceutical enterprises in China. The annual sales revenue is nearly 5 billion yuan, and the export income is more than 100 million US dollars. The company mainly produces 30 kinds of APIs, raw material intermediates and more than 100 kinds of preparation varieties, such as penicillin, cephalosporins, macrolides antibiotics and cardio cerebrovascular drugs. The technical quality indexes of penicillin industrial salt and 7aca are always at the leading level in China and the first-class level in the world. The company has scientific research and development center, quality inspection center, planning and control center, production, sales, service and other systems and functional departments with advanced technology and equipment and perfect management system, and has a capable, professional, rigorous and efficient management team and dedicated, loyal, United and upward staff team. The company has developed three kinds of new drugs, kailanxin, suzulanxin, cefepime, ceftizole, and dozens of new products, including four kinds of new drugs, ceftizoxime sodium, cefotiam hydrochloride, ceftazidime hydrochloride, etc. Ceftriaxone sterile API is an exclusive product in China, which has won the provincial science and Technology Progress Award and the national key new product certificate; the research achievements of ceftriaxone technology have won the national key new product certificate and the first prize of science and technology progress in the pharmaceutical industry. The leading products of the enterprise are penicillin, cephalosporin raw powder and preparations, which have passed GMP certification of the State Drug Administration; potassium salt of penicillin industry has passed FDA certification of the United States; some APIs and preparations have passed GMP certification of the Ministry of health of South Africa; cefazolin sodium and ceftriaxone sodium raw materials have passed edmf certification of Europe. Harbin Pharmaceutical Group Pharmaceutical General Factory is a key antibiotic production and export base in China. The marketing system consists of nine sales companies, 62 offices in 29 provinces, more than 600 salespeople, and more than 5600 distributors, covering all districts and counties except Hong Kong, Macao and Taiwan. The international trade marketing network covers the markets of the Middle East, Southeast Asia, South America, India, Russia, other countries of the former CIS, Africa, EU, etc. its products are exported to more than 40 countries and regions. In 2010, the most valuable brand evaluation in China, the value of "Harbin Pharmaceutical" brand has reached 16.062 billion yuan, becoming the top of China's pharmaceutical industry and the first brand in Heilongjiang Province. Harbin Pharmaceutical Group Pharmaceutical Factory is a state-level contract abiding and trustworthy unit. Harbin pharmaceutical products enjoy a high reputation in the eyes of customers and consumers for their high quality, efficiency and safety. Harbin Pharmaceutical Group Pharmaceutical General Factory adheres to the enterprise spirit of "being virtuous and hardworking and strong", and always takes the development and expansion of the pharmaceutical industry of the motherland and the benefit of human health as its responsibility. It strives to surpass and strive to build a standardized, modern and international pharmaceutical industry with the most scientific and technological strength, business potential, development tension and cultural charm in China, striving to be a society and a person Class creates greater value.

本文链接: https://www.waitui.com/brand/2c2f753da.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

埃隆·马斯克旗下XAI公司正与投资者洽谈 计划融资约200亿美元

埃隆·马斯克旗下的xAI正与投资者洽谈,为其人工智能初创公司及社交媒体业务筹集约200亿美元资金。该笔交易将使公司估值超过1200亿美元,所得资金或可用于偿还马斯克将推特私有化所产生的债务。此轮融资预计将在未来几个月内完成,且有可能筹集到超过200亿美元的资金。数据提供商PitchBook的数据显示,若此笔交易达成,将成为有史以来规模第二大的初创企业融资轮次,仅次于今年早些时候OpenAI获得的400亿美元融资。(财联社)

2小时前

中国重汽与丰田汽车签署战略合作协议

中国重汽与丰田汽车25日在日本名古屋丰田总部签署战略合作协议。双方联合开发的氢燃料电池牵引车已批量交付市场应用。未来,双方将在氢燃料商用车合作研发、示范运营、推广应用、商业模式创新等领域建立更广泛的合作。(财联社)

2小时前

中国人民银行行长潘功胜会见新兴市场经济体央行主要负责人

2025年4月国际货币基金组织/世界银行春季会议期间,中国人民银行行长潘功胜在美国华盛顿会见了韩国央行行长李昌镛、巴西央行行长加利波罗、南非央行行长康亚戈、阿根廷央行行长鲍希利,主要就全球经济金融形势、深化双边务实合作等议题交换了意见。 中方强调,当前全球经济复苏充满不确定性,新兴市场和发展中国家应利用日益增强的政治互信和经济互补,通过多边、双边渠道加强政策协调,推进金融务实合作,维护以多边规则为基础的全球治理秩序。(界面)

2小时前

习近平在中共中央政治局第二十次集体学习时强调,坚持自立自强,突出应用导向,推动人工智能健康有序发展

中共中央政治局4月25日下午就加强人工智能发展和监管进行第二十次集体学习。中共中央总书记习近平在主持学习时强调,面对新一代人工智能技术快速演进的新形势,要充分发挥新型举国体制优势,坚持自立自强,突出应用导向,推动我国人工智能朝着有益、安全、公平方向健康有序发展。(新华社)

2小时前

上海经信委:将推动整车企业转型,加强智能驾驶大模型等创新应用

“智链未来 共赢新章”2025年长三角新能源汽车产业链供应链创新合作大会于4月25日在国家会展中心(上海)召开。上海市经信委二级巡视员、汽车产业处处长韩大东在会上致辞时表示,汽车产业是上海的重点产业之一。在当前全球汽车产业变革调整窗口期、机遇期,上海全力破解汽车产业转型升级的痛点、堵点,加快打造世界级汽车产业中心,推动长三角一体化发展,近年来取得了一定成效。 韩大东强调,当前,全球汽车竞争格局向电动化、智能化、AI化发展,零部件一体化、集成化、轻量化趋势明显。叠加国际贸易摩擦、关税壁垒等地缘政治影响,汽车产业链面临重塑与变革。为加快提升长三角地区汽车产业全链条竞争力,上海将推动整车企业改革转型,加强智能驾驶大模型等创新技术应用,加快智己、奥迪、尚界等新车型投产上市,促进长三角地区及全国汽车产业链上下游协同发展。(澎湃新闻)

2小时前

本页详细列出关于哈药牌的品牌信息,含品牌所属公司介绍,哈药牌所处行业的品牌地位及优势。
咨询